2022
DOI: 10.1016/j.surg.2021.10.012
|View full text |Cite
|
Sign up to set email alerts
|

Elevated preoperative suPAR is a strong and independent risk marker for postoperative complications in patients undergoing major noncardiac surgery (SPARSE)

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
1

Relationship

5
1

Authors

Journals

citations
Cited by 12 publications
(23 citation statements)
references
References 37 publications
0
16
0
Order By: Relevance
“…It is an immune mediator involved in numerous physiological and pathological pathways and its levels in circulation reflect the ability of the patient to cope with diseases. 16 , 17 An increase in suPAR levels can be triggered by various stimuli, including SARS‐CoV‐2, and suPAR is highly expressed in lung tissue, 18 which may be critical for disease progression. Indeed, suPAR has been recently implicated in the evolution of COVID‐19 and its associated complications 12 , 19 , 20 and represents the inflammatory biomarker that is most reflective of the hyperinflammatory state in patients with comorbidities.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is an immune mediator involved in numerous physiological and pathological pathways and its levels in circulation reflect the ability of the patient to cope with diseases. 16 , 17 An increase in suPAR levels can be triggered by various stimuli, including SARS‐CoV‐2, and suPAR is highly expressed in lung tissue, 18 which may be critical for disease progression. Indeed, suPAR has been recently implicated in the evolution of COVID‐19 and its associated complications 12 , 19 , 20 and represents the inflammatory biomarker that is most reflective of the hyperinflammatory state in patients with comorbidities.…”
Section: Discussionmentioning
confidence: 99%
“…It is worthy of note that suPAR is not an acute phase reactant, has no circadian variation, and remains stable during episodes of acute stress. 3 , 8 , 17 Based on the specific characteristics of suPAR and the other markers, a multi‐level approach using key clinical and laboratory data could improve prediction at hospital admission. 27 Thus, we constructed the SALGA model that can best estimate the WHO‐CPS score.…”
Section: Discussionmentioning
confidence: 99%
“…We considered suPAR levels higher than 5.5 ng mL −1 as a clinically important indicator of systemic inflammation, as previously suggested [ 32 ]. A second cut-off at 10 ng mL −1 was chosen to indicate especially high suPAR levels [ 12 ].…”
Section: Methodsmentioning
confidence: 99%
“…Healthy individuals can also be genetically predisposed to higher or lower suPAR levels, which gives suPAR a potential prognostic value in associated diseases [ 6 ]. Of note, mounting evidence from studies including cancer and non-cancer patients suggests that suPAR can serve as an independent predictor of postoperative complications and outcomes compared to other biomarkers [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 ]. This could be explained in part by the stability of suPAR, which is significantly higher than that of other markers (e.g., C-reactive protein (CRP) or proinflammatory cytokines) and remains unaffected by general anesthesia and operative trauma [ 22 ].…”
Section: Introductionmentioning
confidence: 99%
“…The underlying study was conducted in accordance with Good Clinical Practice guidelines, the principles of the Declaration of Helsinki, and relevant regulatory requirements. The original study was registered in ClinicalTrials.gov (NCT03851965, February 22, 2019) [10]. The UHL Institutional Review Board approved the study (IRB no.…”
Section: Methodsmentioning
confidence: 99%